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Abstract
Introduction
The incidence of acute pyelonephritis (APN) in the diabetic population is comparatively higher and tends to
be more complicated, with serious outcomes. Although complicated pyelonephritis (PN) needs hospital
admission and intravenous antibiotics, the magnitude of hospital stay due to comorbidities is limited. This
study's aim was to assess the impact of diabetes mellitus on length of hospital stay among patients with PN.
Methods
We did a retrospective data review of 520 randomly selected hospitalized patients of PN from March 2015 to
December 2019 from a tertiary care center. Electronic medical records were used for identifying medical
conditions through ICD-10 coding. Length of stay (LOS) was categorized as < five days and ≥ five days. Chi‐
squared tests were used to compare categorical parameters. Logistic regression models were used for
multivariate analyses.
Results
The study included 520 patients with PN; 194 (37.3 %) men and 326 (62.7%) women. Overall, there were 353
(67.8 %) and 167 (32.1 %) patients with LOS < five and ≥ five days respectively. Most of the patients had
lower urinary tract symptoms (90%); among them, the majority (92%) were discharged within five days.
Likewise, half of the patients had diabetes (51.2); among them, 53% were discharged after five days. Older
age (OR:1.7, 95%CI: 1.1 - 2.6), upper urinary tract symptoms (OR:1.6, 95%CI: 1.1 - 2.4), lower urinary tract
symptoms (OR:1.9, 95%CI: 1.1 - 3.5), creatinine greater than 1.5 mg/dl (OR:1.6, 95% CI: 1.1 - 2.4) was
positively associated with LOS ≥ 5 days after adjusting for other covariates. Diabetes mellitus was not found
to be associated with LOS ≥ 5 days (OR: 0.9, 95%CI: 0.8 - 1.5).
Conclusion
In patients with acute PN, diabetes mellitus is not independently associated with prolonged hospital stay
beyond five days.
Categories: Internal Medicine, Infectious Disease, Nephrology
Keywords: pyelonephritis, diabetes mellitus, diabetes, urinary tract infections
Introduction
Globally 10.5 million to 25.9 million cases of pyelonephritis (PN) are diagnosed annually, out of which
459,000 to 1,138,000 cases are reported from the United States only [1]. Given the higher prevalence of risk
factors associated with PN, this disease may greatly affect countries from the low and middle-income
regions; however, the exact estimates are limited.
Conventionally, acute PN (APN) used to require hospital admission and intravenous antibiotics. However,
the recent guideline recommends that mild PN may not require hospitalization and can be treated with oral
antibiotics at home. Nevertheless, complicated PN still requires hospitalization for treatment, which has
both clinical and economic consequences [2].
Although the literature on medical conditions that predicts PN is well-known, data on the impact of chronic
diseases that impact the length of stay among patients with PN is not well-reported. Given that the
incidence of acute PN in the diabetic population is comparatively higher, i.e., 12.6% as compared to non-
diabetic patients [3-5], the severe clinical manifestations of PN, such as papillary necrosis, emphysematous
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PN, and bacteremia, were more frequently observed in diabetic patients [6]. In addition, it has been observed
in clinical practice that diabetes mellitus generally results in complicated PN and recurrent
hospitalization and increases mortality [7]. However, it is not known whether it has any impact on the
length of stay (LOS). Our study aims to address this gap and find the association between diabetes mellitus
and length of stay in patients with acute PN needing hospital care.
Materials And Methods
Study design and setting
We conducted a retrospective study in hospitalized patients of PN from March 2015 to December 2019. The
study was reviewed and approved by our institutional review board.
The study was conducted in a tertiary care academic facility in Karachi, Pakistan. With an annual in-patient
census of 6000-8000, approximately 9.63% of patients are being diagnosed as PN [8].
Study subjects
Patients who were 16 years of age or older, with a clinical diagnosis of APN needing intravenous antibiotic
therapy were enrolled in the study. Records of the cases were retrieved through codes using International
Classification of Disease (ICD) 10 Clinical Modification (CM) N-10 for APN and ICD 10 CM E-10 for diabetes
mellitus. The lab results were reviewed through the online portal and patient care services. Of these
patients, we included only those patients with pyuria (the presence of 10 or more leukocytes per high power
field in the centrifuged specimen), fever (body temperature >38 OC), and lumbar tenderness.
Quantitative urine cultures were performed using a standard technique using Columbia blood and CLED
(Cystine-Lactose-Electrolyte-Deficient) agar plates (BioMerieux, Marcy 1’Etoile, France) incubated for 18 to
24 hours at 36°C. Isolated were identified using the analytical profile index (API) system and the Vitek2
automated system (BioMerieux). Susceptibilities were identified using the disk diffusion method or the Vitek
2 system, according to the breakpoints recommended by the Clinical and Laboratory Standard Institute [9].
We also included patients with only pyuria and lumbar tenderness if they had received any antipyretic
medication within the last four hours. Exclusion criteria encompassed the following medical conditions:
pregnancy, renal stones, severe sepsis, renal tumors, polycystic kidneys, or severe hydronephrosis. Patients
getting immunosuppressant medications (steroids, calcineurin inhibitors, anti-metabolites, or cytotoxic
agents) were also excluded.
Measures and outcomes
The standardized extraction of demographic and clinical data from electronic medical records was
performed by trained data abstractors. The clinical information abstracted included age, co-morbidities,
including diabetes mellitus and hypertension, physical findings like fever and costovertebral angle
tenderness, and length of hospital stay.
Continuous variables were dichotomized: age <50 years and >50 years. Serum creatinine < 1.5 mg/dl and ≥
1.5 mg/dl. The main outcome measure was LOS as < five days and ≥ five days.
Data analysis
Continuous data were briefed as mean and standard deviations. Categorical data were summarized as
percent frequency of occurrence. Correlation between predictor variables (patient demographics and clinical
characteristics) and LOS were analyzed by univariate and multivariate methodologies. For determining the
characteristics associated with LOS (> 5 days), stepwise multivariate logistic regression models based on a
maximum likelihood estimate method were applied. The crude and adjusted odds ratios (aOR) and 95%
confidence intervals (95% CI) are presented. Analyses were done using the Statistical Package for the Social
Sciences (SPSS) for Windows 10 (SPSS Inc, Chicago, IL).
Results
Table 1 shows the characteristics of PN patients included in the cohort. During the study period, 520
patients with APN were enrolled. Of these 520 patients, 194 (37.3%) were male, whereas 364 (62.7%) were
females. There were 267 (51.3%) APN patients who had diabetes, whereas 253 were non-diabetic. Altogether,
48.8% patients were hypertensive; half of them were discharged within five days. More than half of the
patients (51.2%) discharged after five days had creatinine higher than 1.5 mg/dl. There were about 68.9% of
patients who had upper urinary tract symptoms while 91.8% had presented with lower urinary tract
symptoms only. The results of the main analysis from the logistic regression model examining the
characteristics associated with LOS (< 5 versus ≥ 5 days) are presented in Table 2. Diabetes mellitus was not
found to be independently associated with LOS ≥ 5 days (OR: 0.9, 95% CI: 0.8 - 1.5). Other covariates for
which the model was adjusted, including age (OR: 1.7, 95% CI: 1.1 - 2.6), upper (OR: 1.6, 95% CI: 1.1 -
2.4) and lower urinary symptoms (OR: 1.9, 95% CI: 1.1 - 3.5), and medical comorbidities, including higher
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creatinine (OR: 1.6, 95% CI: 1.1 - 2.4), were found to be associated LOS (≥ 5 days). However, gender (OR: 1.1,
95%CI: 0.6 - 1.5), fever (OR: 1.2, 95%CI: 0.8 - 1.7), hypertension (OR: 0.9, 95%CI: 0.6 - 1.3), and total
leucocyte count (TLC) (OR: 1.0, 95%CI: 0.9 - 1.0) were not found to be associated with the outcome.
 
 Total Length of stay  Crude Estimates
 N % <5 days >5 days  OR 95%CI
Age in years          
<50 years 153 29.4% 116 32.9% 37 22.2%  1  
>50 years 367 70.6% 237 67.1% 130 77.8%  1.7 1.1-2.6
          
Gender          
Female 326 62.7% 222 62.9% 104 62.3%  1  
Male 194 37.3% 131 37.1 63 37.7%  0.9 0.6-1.4
          
URINARY TRACT SYMPTOMS         
Upper          
Negative 146 28.1% 58 34.7% 88 24.9%  1  
Positive 374 71.9% 109 65.3% 265 75.1%  1.6 1.1-2.3
Lower          
Negative 52 10% 23 13.8% 29 8.2%  1  
Positive 468 90% 144 86.2% 324 91.8%  1.7 0.9-1.3
          
Fever          
No 204 39.2% 134 38% 70 42%  1  
YES 316 60.8% 219 62% 97 58.1%  1.1 0.8-1.7
          
DM          
No 253 48.7% 175 49.6% 78 46.7%  1  
YES 267 51.3% 178 50.4% 89 53.3%  1.1 0.7-1.6
HTN          
No 266 51.2% 180 51% 86 51.5%  1  
YES 254 48.8% 173 49% 81 48.5%  0.9 0.6-1.4
          
Creatinine (mg/dl)          
<1.5 298 57.3% 217 61.5% 81 48.5%  1  
>1.5 222 42.7% 136 38.5% 86 51.5%  1.6 1.1-2.4
          
Urine Culture          
E. coli (All types) 231 44.4% 157 44.5% 74 44.3%  N/A  
Gram-negative (Except E. coli) 244 46.9% 168 47.6% 76 45.5%    
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Gram-positive 17 3.3% 12 3.4% 5 3%    
Candida species 28 5.4% 16 4.5% 12 7.2%    
          
TABLE 1: Sociodemographic and clinical characteristics of APN patients admitted in a tertiary
care hospital (Total=520)
APN: acute pyelonephritis; DM: diabetes mellitus; HTN: hypertension; E. coli: Escherichia coli
 
 Length of Stay 95%CI
 a OR   
AGE    
<50 years 1   
>50 years 1.7  1.1-2.6
    
 GENDER    
 Female 1   
Male 1.1  0.6-1.5
    
URINARY TRACT SYMPTOMS    
    
Upper    
Negative 1   
Positive 1.6  1.1-2.4
Lower    
Negative 1   
Positive 1.9  1.1-3.5
    
FEVER    
No 1   
YES 1.2  0.8-1.7
    
DIABETES MELLITUS    
No 1   
YES 0.9  0.8-1.5
HYPERTENSION    
No 1   
Yes 0.9  0.6-1.3
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Creatinine (mg/dl)    
<1.5 1   
>1.5 1.6  1.1-2.4
    
TLC 1.0  0.9-1.0
TABLE 2: Association of APN with length of stay in hospitalized patients
APN: acute pyelonephritis; TLC: total leucocyte count
Discussion
This study investigated the potential differences in the clinical and microbiological features of diabetic PN
patients with a length of stay. The results showed that diabetes mellitus (DM) was not associated with a
prolonged length of stay in hospitalized patients with APN. This is in contrast to the higher odds ratios
ranging from 1.7 to 4.7 returned by the previous studies [10-11]. A possible explanation for these null
findings could be that the older studies had more complicated cases and a lower number of sample sizes (111
and 388 vs 520 in our study) [12]. Another plausible difference is in the difference of the operational
definition of the length of stay, as earlier studies took the lengthier cut off for the duration of
hospitalization. However, with the feasible use of outpatients parenteral antibiotic therapy (OPAT) in PN,
LOS has shortened to a mean duration of three days [13], thus this study has set a five-day cutoff for
complicated cases of PN who were hospitalized, which depicts a real-world scenario. Usually, uncomplicated
cases have even shorter stays.
Advanced age is considered to be an independent complicating factor of PN [14]. It is easily identified during
the initial presentation of PN and can be used for categorizing the PN or forecasting the prognosis. Most of
our studied population was above 50 years old (70%), with a mean age of 57.3 years. After adjusting for
confounders, our study showed higher odds of delayed discharge as compared to younger-age group
patients. As the elderly are known to have a higher number of comorbid conditions and poor immune
mechanisms, it is plausible to link advanced age with poor prognosis in APN patients. These findings are in
accord with most of the published data on APN, mandating it to be considered as a significant risk for
complications in PN [14-15].
Our clinical data established that the frequency of both upper and lower urinary tract symptoms and signs
vary significantly, as of all the diagnosed APN cases, 41% did not have any upper tract symptoms. Therefore,
symptomatic patients may exhibit an atypical presentation of clinical symptoms/ signs, that it had a
prolonged hospital stay as compared to those who presented without upper or lower tract symptoms. Occult
PN is an easily missed entity and accounts for a small portion of all PN admissions [16]. Asymptomatic
mildly symptomatic patients usually get an early discharge on oral antibiotics.
In the absence of overt complications, PN patients usually discharge within five days of hospitalization [17].
Our study showed 51.3% had less than five days of stay in the hospital with a mean length of stay of 5.36
days. Recently, literature increasingly uses the shorter duration of hospital stay to gauge the quality of care
[17-18].
The present study found no association between gender, hypertension, high fever (≥ 39°C or even ≥ 40°C), or
a high white blood cell (WBC) count (>12,000 /Ul or even >20,000/uL) and discharge, which advocates that
high fever and a high WBC count do not influence discharge plan. We infer that these differences are
attributable to the different study populations. Earlier studies are conducted commonly using intravenous
agents with a prolonged duration of antibiotics course, which, at times, warrants hospital stay for the ease of
intravenous delivery and course completion under monitoring.
Nowadays, a newer version of oral fluoroquinolones and cephalosporin are proven to improve bioavailability
and effectiveness, which can be safely taken at home [19]. The clinician feels more confident to send the
patient home with a stable infection after an initial response to the treatment within a few days.
Our study findings need to be interpreted in light of certain shortcomings. We collected retrospective data of
clinical and biochemical parameters from in-hospital records. It was conducted at a single center and hence
carries all the weaknesses of a single-center design. We were not able to capture the management strategies
or the patient’s ability to take oral medication, which could also confound the length of stay. Moreover, the
study was conducted in an adult population, thus inferences cannot be extrapolated in the pediatric age
group, which holds a substantial percentage of the disease group. Since our hospital structure is private and
there is a service fee, patients may have influenced the discharge decision. Finally, as this was a cross-
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sectional study, a cause-effect relationship cannot be determined, but further prospective studies in lieu of
newer antibiotic agents and home health services should be performed to confirm and better define the
nature of this association between diabetes mellitus and LOS among patients with PN.
Conclusions
This study shows that in patients with PN, DM, and hypertension, fever or TLC count are not independently
associated with prolonged length of stay, however, an increasing age, high creatine levels, urinary
symptoms, upper tract, and lower tract separately were independently associated with delayed hospital
discharge beyond five days.
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